Blood tests may unlock secrets of heart failure in metabolic syndrome

NCT ID NCT02446327

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at blood samples from 47 patients in France (part of a larger European study) to find biological markers linked to diastolic heart failure in people with metabolic syndrome. The goal was to confirm earlier findings about these markers. Participants had signs of heart failure but no recent heart attack or major health issues. The study did not test any treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help identify biological markers to better diagnose or predict diastolic heart failure in people with metabolic syndrome.

What could go wrong

This is an observational study, not a treatment trial. It only looks for patterns in blood samples, so it won't directly improve health. Results may not lead to new tests or therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIASTOLIC HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diastolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.